Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00030550
Status:
COMPLETED
Last Update Posted:
2013-01-31
First Post:
2002-02-14
Brief Title:
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| MyelodysplasticMyeloproliferative Neoplasms |
| Leukemia |
| Myelodysplastic Syndromes |
Keywords:
| Name | View |
|---|---|
| atypical chronic myeloid leukemia BCR-ABL1 negative | View |
| refractory anemia | View |
| refractory anemia with ringed sideroblasts | View |
| refractory anemia with excess blasts | View |
| de novo myelodysplastic syndromes | View |
| chronic myelomonocytic leukemia | View |
| previously treated myelodysplastic syndromes | View |
| myelodysplasticmyeloproliferative neoplasm unclassifiable | View |